Gonorrhea
Cross-source consensus on Gonorrhea from 1 sources and 4 claims.
1 sources · 4 claims
Risks & contraindications
Other
Other
Other
Highlighted claims
- Antimicrobial resistance in N. gonorrhoeae is a critical threat because resistance has developed to every antibiotic class used against it. — Efficacy of the serogroup B Neisseria meningitidis vaccine (4CMenB) in preventing experimental Neisseria gonorrhoeae urethral infection: a double-blind randomised controlled human challenge study protocol
- Gonorrhea causes about 90 million new cases worldwide each year. — Efficacy of the serogroup B Neisseria meningitidis vaccine (4CMenB) in preventing experimental Neisseria gonorrhoeae urethral infection: a double-blind randomised controlled human challenge study protocol
- Gonorrhea can infect the urethra in men and the cervix in women and can ascend into the upper reproductive tract. — Efficacy of the serogroup B Neisseria meningitidis vaccine (4CMenB) in preventing experimental Neisseria gonorrhoeae urethral infection: a double-blind randomised controlled human challenge study protocol
- Up to 45% of gonorrhea infections are asymptomatic. — Efficacy of the serogroup B Neisseria meningitidis vaccine (4CMenB) in preventing experimental Neisseria gonorrhoeae urethral infection: a double-blind randomised controlled human challenge study protocol